What is MAIA's current stock price?

MAIA (MAIA Biotechnology, Inc.) is currently trading at $1.15 with a market cap of $69.9M.

What sector is MAIA Biotechnology, Inc. in?

MAIA Biotechnology, Inc. (MAIA) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

MAIA MAIA Biotechnology, Inc.

AMEXHealthcare

$1.15-2.54%ClosedMarket Cap: $69.9M

As of 2026-10-08 16:00

Why MAIA matters now

MAIA Biotechnology, Inc. (MAIA) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.15 with -2.54% on the session and $69.9M in market capitalization.

The latest indexable market news headline is "MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer" from GlobeNewsWire.

Latest News

MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung CancerGlobeNewsWire · 2026-10-07

Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)GlobeNewsWire · 2026-10-01

MAIA: Meta Taps MongoDB CEO to Lead New Enterprise AI Platform, ft. Seth Fiegerman | Open InterestBloomberg Markets and Finance · 2026-09-28

MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and PortugalGlobeNewsWire · 2026-09-23

MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung CancerGlobeNewsWire · 2026-09-22

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

AMEX

Beta

0.28

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.